Overview

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)

Status:
Completed
Trial end date:
2020-12-21
Target enrollment:
Participant gender:
Summary
This trial investigates the effects of FE 999049 compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Follicle Stimulating Hormone